Short answer
Stryker Corporation (SYK) filed its Q2 2026 10-Q quarterly report on Jul 31, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $6.6B (up 9.4% year over year) with net income of $1.3B.
Q2 2026 key financials · XBRL
- Revenue
- $6.6B
- +9.4% YoY · +9.5% QoQ
- Net income
- $1.3B
- +44.3% YoY · +71.3% QoQ
- Operating margin
- 25.2%
- Gross margin
- 68.3%
- EPS (diluted)
- $3.30
- +44.1% YoY · +71.0% QoQ
Source: XBRL data from the Stryker Corporation (SYK) Q2 2026 10-Q on SEC EDGAR. USD.
Stryker Corporation Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $6,589M, up 9.4% YoY from $6,022M
- Operating margin 25.2% vs 18.5% YoY; gross margin 68.3% vs 63.8%
- Best segment Medical revenue $1,122M, up 13.4%; worst Vascular revenue $496M, down 0.7%
- Operating income $1,659M vs $1,113M; net earnings $1,276M vs $884M
- Outlook: MedSurg and Neurotechnology growth expected to outpace Orthopaedics, creating unfavorable segment-mix pressure
Risk Factors
- No risk-factors section provided in the filing excerpt
- No quarter-specific changes identifiable versus the most recent 10-K
- Excerpt contains equity issuance, repurchase authorization, and executive trading disclosures only
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Stryker Corporation quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.